• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Next-generation genomic profiling of hepatocellular adenomas: a new era of individualized patient care.肝细胞腺瘤的下一代基因组分析:个体化患者治疗的新时代。
Cancer Cell. 2014 Apr 14;25(4):409-11. doi: 10.1016/j.ccr.2014.03.032.
2
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.对肝细胞腺瘤的基因组分析揭示了 FRK 激活突变的重现和恶性转化的机制。
Cancer Cell. 2014 Apr 14;25(4):428-41. doi: 10.1016/j.ccr.2014.03.005.
3
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
4
Hepatocellular adenoma: Where are we now?肝细胞腺瘤:我们现在在哪里?
World J Gastroenterol. 2022 Apr 14;28(14):1384-1393. doi: 10.3748/wjg.v28.i14.1384.
5
Malignant transformation of hepatic adenomas.肝腺瘤的恶性转化
Mod Pathol. 2008 Apr;21(4):491-7. doi: 10.1038/modpathol.2008.8. Epub 2008 Feb 1.
6
Whole-exome sequencing-based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma.基于全外显子组测序的肝细胞腺瘤恶性转化为肝细胞癌的突变特征分析。
Clin Exp Pharmacol Physiol. 2024 Jul;51(7):e13901. doi: 10.1111/1440-1681.13901.
7
Hepatocellular adenomas: review of pathological and molecular features.肝细胞腺瘤:病理和分子特征综述。
Hum Pathol. 2021 Jun;112:128-137. doi: 10.1016/j.humpath.2020.11.016. Epub 2020 Dec 9.
8
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.Somatic HNF1A 突变在肝细胞腺瘤恶性转化中的作用:MSK-IMPACT 和 TCGA 数据的回顾性分析。
Hum Pathol. 2019 Jan;83:1-6. doi: 10.1016/j.humpath.2018.08.004. Epub 2018 Aug 17.
9
gene rearrangement: a powerful driver of β-catenin activation in liver tumours.基因重排:肝脏肿瘤中β-连环蛋白激活的强大驱动因素。
Gut. 2019 Jul;68(7):1287-1296. doi: 10.1136/gutjnl-2018-317632. Epub 2019 Feb 2.
10
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.利用 microRNA 谱分析和靶向基因测序对肝细胞腺瘤和癌进行特征分析。
PLoS One. 2018 Jul 27;13(7):e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018.

引用本文的文献

1
The Different MRI Features of Hepatocellular Adenoma and Hepatocellular Carcinoma.肝细胞腺瘤与肝细胞癌的不同磁共振成像特征
J Pharm Bioallied Sci. 2023 Jul;15(Suppl 2):S1046-S1049. doi: 10.4103/jpbs.jpbs_230_23. Epub 2023 Jul 11.
2
Functional and genetic deconstruction of the cellular origin in liver cancer.肝癌中细胞起源的功能和遗传解构。
Nat Rev Cancer. 2015 Nov;15(11):653-67. doi: 10.1038/nrc4017.
3
Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis.肝细胞腺瘤分子剖析的当前进展:诊断综述与实用指南
Int J Mol Sci. 2015 Sep 2;16(9):20994-1007. doi: 10.3390/ijms160920994.
4
Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.肝癌肿瘤基因组学:临床应用的机遇与困境
Hepat Oncol. 2015;2(1):79-93. doi: 10.2217/hep.14.24.

本文引用的文献

1
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.肝细胞癌和癌前病变中端粒酶逆转录酶启动子体细胞突变的高频。
Nat Commun. 2013;4:2218. doi: 10.1038/ncomms3218.
2
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.全基因组测序鉴定肝细胞癌中的复发性突变。
Genome Res. 2013 Sep;23(9):1422-33. doi: 10.1101/gr.154492.113. Epub 2013 Jun 20.
3
Cancer genome landscapes.肿瘤基因组图谱。
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
4
Hepatocellular benign tumors-from molecular classification to personalized clinical care.肝细胞良性肿瘤——从分子分类到个体化临床治疗。
Gastroenterology. 2013 May;144(5):888-902. doi: 10.1053/j.gastro.2013.02.032. Epub 2013 Feb 26.
5
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.人类炎症性肝细胞腺瘤中激活 STAT3 的体细胞突变。
J Exp Med. 2011 Jul 4;208(7):1359-66. doi: 10.1084/jem.20110283. Epub 2011 Jun 20.
6
Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.重新审视使用新免疫组织化学标志物的切除良性肝细胞结节的病理学。
Semin Liver Dis. 2011 Feb;31(1):91-103. doi: 10.1055/s-0031-1272837. Epub 2011 Feb 22.
7
Changing trends in malignant transformation of hepatocellular adenoma.肝细胞腺瘤恶变的变化趋势。
Gut. 2011 Jan;60(1):85-9. doi: 10.1136/gut.2010.222109.
8
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.频繁的框内体细胞缺失激活炎症性肝细胞肿瘤中的gp130。
Nature. 2009 Jan 8;457(7226):200-4. doi: 10.1038/nature07475. Epub 2008 Nov 19.
9
The epigenomics of cancer.癌症的表观基因组学。
Cell. 2007 Feb 23;128(4):683-92. doi: 10.1016/j.cell.2007.01.029.
10
Bi-allelic inactivation of TCF1 in hepatic adenomas.肝腺瘤中TCF1的双等位基因失活。
Nat Genet. 2002 Oct;32(2):312-5. doi: 10.1038/ng1001. Epub 2002 Sep 23.

肝细胞腺瘤的下一代基因组分析:个体化患者治疗的新时代。

Next-generation genomic profiling of hepatocellular adenomas: a new era of individualized patient care.

机构信息

Laboratory of Experimental Carcinogenesis (LEC), Center for Cancer Research, National Cancer Institute, NIH, 37 Convent Drive, Room 4146, Bethesda, MD 20892, USA; Department of Medicine I, Johannes Gutenberg University, 55131 Mainz, Germany.

Laboratory of Experimental Carcinogenesis (LEC), Center for Cancer Research, National Cancer Institute, NIH, 37 Convent Drive, Room 4146, Bethesda, MD 20892, USA.

出版信息

Cancer Cell. 2014 Apr 14;25(4):409-11. doi: 10.1016/j.ccr.2014.03.032.

DOI:10.1016/j.ccr.2014.03.032
PMID:24735920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4078407/
Abstract

Hepatocellular adenomas (HCAs) are clinically relevant benign liver lesions that commonly occur in women on hormonal contraceptives. In this issue of Cancer Cell, Pilati and colleagues present an integrative multi-"omics"-based analysis of HCA and identify recurrent genetic alterations associated with adenoma-carcinoma transition and new drugable targets.

摘要

肝细胞腺瘤(HCA)是临床上有意义的良性肝病变,常见于使用激素避孕药的女性。在本期《癌细胞》杂志中,Pilati 及其同事对 HCA 进行了基于整合多组学的分析,鉴定出与腺瘤-癌转化相关的复发性遗传改变和新的可用药靶标。